Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | May 15, 2025 | May 16, 2025 |
| Huron Consulting Group Inc.HURN · Entity 4332 | Director | April 01, 2020 | April 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 15, 2025 · Filed May 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,575 |
Ending reported balance
After 2025-05-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-05-15 · Sale · Disposed 35 · Balance 5,680 F1: This transaction was executed in multiple trades at prices ranging from $136.07 to $136.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. Row 2 · 2025-05-15 · Sale · Disposed 81 · Balance 5,599 F2: This transaction was executed in multiple trades at prices ranging from $137.19 to $138.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. Row 3 · 2025-05-15 · Sale · Disposed 24 · Balance 5,575 F3: This transaction was executed in multiple trades at prices ranging from $139.02 to $139.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $136.07 to $136.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
F2: This transaction was executed in multiple trades at prices ranging from $137.19 to $138.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
F3: This transaction was executed in multiple trades at prices ranging from $139.02 to $139.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024.
Huron Consulting Group Inc.
Report date April 01, 2020 · Filed April 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,719 |
Reported balance
After 2020-04-01 transaction · row 1
1 source rowRow 1 · 2020-04-01 · Sale · Disposed 760 · Balance 17,719 F1: Automatic sale pursuant to a 10b5-1 plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Automatic sale pursuant to a 10b5-1 plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2018 Filed Apr 3, 2018 19:35 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 503 | $37.36 | $18,792.08 |
DisclosureSEC source: 0001140361-18-016734 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,241 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.85 to $37.80. The undersigned undertakes to provide Huron Consulting Group Inc. ("Huron"), any security holder of Huron or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 14:41 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 603 | $40.66 | $24,517.98 |
DisclosureSEC source: 0001140361-18-000658 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,744 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.50 to $40.90. The undersigned undertakes to provide Huron Consulting Group Inc. ("Huron"), any security holder of Huron or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 14:40 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 603 | $34.88 | $21,032.64 |
DisclosureSEC source: 0001140361-17-037540 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,347 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $35.15. The undersigned undertakes to provide Huron Consulting Group Inc. ("Huron"), any security holder of Huron or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 14, 2017 Filed Feb 7, 2018 13:15 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 1,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004440 · form5.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,051 Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 17:04 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $101.43 | $10,143.00 |
DisclosureSEC source: 0001127602-17-023733 · form4.xml · nonDerivative · entry 2 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,701 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 17:04 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $101.33 | $10,133.00 |
DisclosureSEC source: 0001127602-17-023733 · form4.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,801 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 4,030 | $0.00 Strike: $43.39 | $0.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · derivative · entry 31 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,030 shares Expires 2020-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $101.32 | $10,132.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 30 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,901 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $101.15 | $30,345.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 29 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,001 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $101.00 | $10,100.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 28 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,301 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $100.97 | $20,194.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 27 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,401 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.96 | $10,096.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 26 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,601 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.93 | $10,093.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 25 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,701 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.92 | $10,092.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 24 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,801 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.91 | $10,091.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 23 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,901 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $100.89 | $30,267.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 22 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,001 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $100.87 | $20,174.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 21 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,301 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.85 | $10,085.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 20 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,501 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.84 | $10,084.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 19 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,601 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $100.82 | $20,164.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 18 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,701 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.81 | $10,081.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 17 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,901 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $100.80 | $20,160.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 16 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,001 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $100.78 | $20,156.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 15 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,201 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10 | $100.72 | $1,007.20 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 14 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,401 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.71 | $10,071.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 13 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,411 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 95 | $100.70 | $9,566.50 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 12 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,511 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 224 | $100.67 | $22,550.08 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 11 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,606 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $100.65 | $20,130.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 10 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,830 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.64 | $10,064.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 9 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,030 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.63 | $10,063.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 8 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,130 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1 | $100.61 | $100.61 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 7 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,230 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.59 | $10,059.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 6 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,231 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.54 | $10,054.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 5 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,331 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.52 | $10,052.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 4 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,431 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.46 | $10,046.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 3 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,531 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $100.26 | $10,026.00 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 2 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,631 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| July 17, 2017 Filed Jul 18, 2017 16:51 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 4,030 | $43.39 | $174,861.70 |
DisclosureSEC source: 0001127602-17-023729 · form4.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 13:47 UTC | Huron Consulting Group Inc. HURN · Entity 4332 | SaleCommon Stock | 602 | $43.31 | $26,072.62 |
DisclosureSEC source: 0001140361-17-027270 · doc1.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,950 F1 · kind: Automatic sale pursuant to a 10b5-1 plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.20 to $43.40. The undersigned undertakes to provide Huron Consulting Group Inc. ("Huron"), any security holder of Huron or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 130 | $88.84 | $11,549.20 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 12 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,701 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.78 | $8,878.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 11 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,831 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.51 | $8,851.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 10 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,931 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.50 | $8,850.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 9 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,031 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.31 | $8,831.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 8 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,131 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.28 | $8,828.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 7 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,231 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.13 | $8,813.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 6 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,331 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.07 | $8,807.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 5 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,431 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.98 | $8,798.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 4 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,531 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.94 | $8,794.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 3 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,631 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.85 | $8,785.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 2 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,731 F2 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| May 12, 2017 Filed May 15, 2017 19:26 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-018056 · form4.xml · nonDerivative · entry 1 MASSARO GEORGE · CIK 0001221496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,831 F1 · kind: Consists of 2,436 unvested restricted stock units that vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.